MARKET

INM

INM

Inmed Pharmaceuticals Inc
NASDAQ
0.3468
+0.0017
+0.49%
Pre Market: 0.3790 +0.0322 +9.28% 08:28 03/28 EDT
OPEN
0.3500
PREV CLOSE
0.3451
HIGH
0.3570
LOW
0.3320
VOLUME
1.42K
TURNOVER
0
52 WEEK HIGH
2.080
52 WEEK LOW
0.2913
MARKET CAP
2.10M
P/E (TTM)
-0.2102
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at INM last week (0318-0322)?
Weekly Report · 3d ago
InMed Pharmaceuticals Granted Nasdaq Compliance Extension
TipRanks · 03/20 17:52
InMed Pharmaceuticals Receives Nasdaq Extension
TipRanks · 03/20 13:08
InMed Pharmaceuticals gets 180-Day extension to regain compliance with Nasdaq
InMed Pharmaceuticals gets 180-Day extension to regain compliance with Nasdaq. The company has been granted an additional 180-day compliance period until September 16, 2024. The Nasdaq has no immediate effect on the listing or trading of the company's shares. Healthcare InMed pharmaceuticals Inc. (INM)
Seeking Alpha · 03/20 12:38
Weekly Report: what happened at INM last week (0311-0315)?
Weekly Report · 03/18 12:30
Weekly Report: what happened at INM last week (0304-0308)?
Weekly Report · 03/11 12:24
InMed Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 16/098,324 Titled "Use Of Topical Formulations Of Cannabinoids In The Treatment Of Epidermolysis Bullosa And Related Connective Tissue Disorders"
Benzinga · 03/07 21:00
Weekly Report: what happened at INM last week (0226-0301)?
Weekly Report · 03/04 12:29
More
About INM
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceutical products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 is used for the treatment of glaucoma.

Webull offers InMed Pharmaceuticals Inc stock information, including NASDAQ: INM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INM stock methods without spending real money on the virtual paper trading platform.